Summary Information:
Daxor Corporation Common Stock
AMEX:DXR


email
admin@troach.net
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Daxor Corporation Common Stock
Exchange: AMEX
Symbol: DXR
SEC CIK: 0000027367
Phone: 212-330-8500
350 FIFTH AVENUE
SUITE 4740
NEW YORK NY 10118
CEO:
Price when page updated: 7.49 Date: 2023-11-30
Company Website:
www.daxor.com

_Description: Daxor Corporation is the global leader in blood volume measurement technology focused on blood volume testing innovation (organized as an investment company with fully-owned innovative medical instrumentation and biotechnology operations). Daxor Corporation developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. The BVA technology enhances hospital performance metrics in a broad range of surgical and medical conditions, including heart failure and critical care, by informing treatment strategies, resulting in significantly improved multiple measures of patient outcomes. Daxor's mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor's vision is optimal blood volume for all.

IPO YEAR:

Sector:
Health Care
Industry:
Medical/Dental Instruments
ADRTSO:

MarketCap:
31429403.00
Beta:

52 Week High:
17.58
52 Week Low:
8.58
52 Week Change:
-0.14364640883977908
Short Interest:

Short Date:

Shares Outstanding:
4033877
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
27 Oct 2022
Float:
0
return on Equity:
10.40%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
N/A
ttmEPS:
0
Revenue:
N/A
Gross Profit:

Cash:

Debt:

Institution Percent:
3.70%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
19.40%
Return on Assets:
3.40%
Return on Capital:

Profit Margin:
1.80%
Price to Sales:
0.62
Price To Book:
3.50
Short Ratio:
1.78
PE Ratio:
0
Employees:
0
1Y Guesstimate
N/A:N/A:N/A




__The following are links to various summary and news pages for
__Daxor Corporation Common Stock [ DXR ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-11-30